Cas:698-63-5 5-Nitrofuraldehyde manufacturer & supplier

We serve Chemical Name:5-Nitrofuraldehyde CAS:698-63-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5-Nitrofuraldehyde

Chemical Name:5-Nitrofuraldehyde
CAS.NO:698-63-5
Synonyms:MFCD00003230;5-Nitrofuraldehyde;2-Furancarboxaldehyde, 5-nitro-;5-Nitrofuran-2-carbaldehyd;EINECS 211-816-3;5-Nitro-furanaldehyde;5-Nitro-2-furaldehyde;5-nitrofuran-2-carbaldehyde
Molecular Formula:C5H3NO4
Molecular Weight:141.082
HS Code:29321900

Physical and Chemical Properties:
Melting point:37-39 °C(lit.)
Boiling point:252.2±0.0 °C at 760 mmHg
Density:1.5±0.1 g/cm3
Index of Refraction:1.580
PSA:76.03000
Exact Mass:141.006210
LogP:0.51

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 1325 4.1/PG 2
Packing Group:III


Contact us for information like MFCD00003230 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-nitrofuran-2-carbaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-Nitrofuran-2-carbaldehyd Use and application,5-Nitro-furanaldehyde technical grade,usp/ep/jp grade.


Related News: These have since been joined by many other types of enzyme, including transaminases, oxidases, nitrilases, aldolases, and ammonia lyases, all of which perform distinct functions. (S)-7-chloro-3-(3-hexyl-4-methylphenyl)-2-oxo-4-(2-(piperidin-2-yl)ethoxy)-N-(pyrimidin-4-yl)-1,2-dihydroquinoline-6-carboxamide manufacturers Moderna filed an application with the FDA for that same younger age group on June 10 but has yet to hear from the agency. States like Rhode Island have already signed off on allowing 12 to 17-year-olds to use the vaccine. 11-methyl-12,13,14,15-tetradehydro-7H-benzocyclotridecen-7-one oxime suppliers Earlier this year, the US Food and Drug Administration approved Verquvo to reduce the risk of cardiovascular death and heart failure hospitalisation, following a hospitalisation for heart failure or need for outpatients intravenous (IV) diuretics in adults with symptomatic chronic heart failure and ejection fraction less than 45%. methyl (E)-6-((4-(benzyloxy)-1-iodonaphthalen-2-yl)(tert-butoxycarbonyl)amino)hex-2-enoate vendor & factory.